Kidney TransplantationLiver TransplantationTransplantation, HomologousAcademic Medical CentersBone Marrow TransplantationHeart TransplantationHematopoietic Stem Cell TransplantationLung TransplantationGraft RejectionTransplantation, AutologousGraft SurvivalTissue DonorsTransplantationImmunosuppressive AgentsStem Cell TransplantationTransplantation ConditioningRetrospective StudiesTreatment OutcomeTransplantsOrgan TransplantationTransplantation ImmunologyIslets of Langerhans TransplantationLiving DonorsPancreas TransplantationTime FactorsTissue and Organ ProcurementCell TransplantationGraft vs Host DiseaseTransplantation ChimeraPostoperative ComplicationsHeart-Lung TransplantationImmunosuppressionTransplantation, HeterotopicTransplantation, IsogeneicWaiting ListsFetal Tissue TransplantationHistocompatibility TestingLiver FailureTacrolimusCord Blood Stem Cell TransplantationCyclosporineFollow-Up StudiesTransplantation ToleranceRecurrenceRisk FactorsCadaverPeripheral Blood Stem Cell TransplantationSurvival RateSurvival AnalysisHistocompatibilityKidney Failure, ChronicSkin TransplantationProspective StudiesHematologic NeoplasmsBrain Tissue TransplantationCytomegalovirus InfectionsMycophenolic AcidCorneal TransplantationWhole-Body IrradiationTissue TransplantationTransplantation, HeterologousLiver DiseasesHospitals, VeteransUnited StatesBronchiolitis ObliteransPrognosisHLA AntigensMesenchymal Stem Cell TransplantationIncidenceFacial TransplantationAcute DiseaseImmunocompromised HostCohort StudiesAntilymphocyte SerumPatient SelectionLeukemiaBiopsyPostoperative PeriodCombined Modality TherapyEnd Stage Liver DiseaseBusulfanMultivariate AnalysisRisk AssessmentDonor SelectionBlood Group IncompatibilityAnemia, AplasticAge FactorsOpportunistic InfectionsInfectionTertiary Care CentersIsoantibodiesTissue and Organ HarvestingKaplan-Meier EstimateDisease-Free SurvivalKidneyPrimary Graft DysfunctionBrain DeathMice, Inbred C57BLOrgan PreservationLymphoproliferative Disorders